Genomics, Proteomics, and the Nervous System

This newest volume of Advances in Neurobiology discusses the utilization of genomic and proteomic technologies, to address facets of neurobiology including development and epigenetic regulation, functions in learning and memory, and changes associated with neurological and psychiatric disorders.

James D Clelland, PhD is a Research Scientist at the Nathan Kline Institute for Psychiatric Research, and an Assistant Professor at New York University School of Medicine, in the Department of Psychiatry. His research interests include understanding the biochemical and molecular changes that underlie susceptibility to, and the etiology of, psychiatric illnesses.